Rosuvastatin (20, 40 and 80 MG) reduces LDL-C, raises HDL-C and achieves treatment goals more effectively than atorvastatin (20, 40 and 80 MG) in patients with heterozygous familial hypercholesterolaemia
- 31 May 2001
- journal article
- abstracts
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 2 (2) , 90-91
- https://doi.org/10.1016/s1567-5688(01)80227-0
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit: